Literature DB >> 2991926

Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene.

J Sorge, T Gelbart, C West, B Westwood, E Beutler.   

Abstract

A cloned fragment of human glucocerebrosidase cDNA has been used as a probe to study restriction polymorphisms in the region of the gene for Gaucher disease. Variability in the size of fragments produced by digestion with the restriction endonucleases Pvu II and Kpn I was discovered. The Pvu II polymorphism was found to be a very prevalent one with a gene frequency of 0.65 for the Pv1.1- allele and 0.35 for the Pv1.1+ allele. Similar frequencies were encountered among diverse ethnic groups. Five of eight Jewish patients with Gaucher disease were found to be heterozygous for the Pvu II restriction polymorphism. One non-Jewish patient with type I Gaucher disease was heterozygous for the Kpn I variant. The existence of Gaucher disease genes in association with either allele of the ancient Pvu II polymorphism clearly indicates that, even within the Jewish population, the Gaucher disease mutation has occurred independently more than once. Presumably, different mutations have also occurred in the non-Jewish population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991926      PMCID: PMC390585          DOI: 10.1073/pnas.82.16.5442

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  Gaucher's disease in an asymptomatic 72-year-old.

Authors:  E Beutler
Journal:  JAMA       Date:  1977-06-06       Impact factor: 56.272

3.  Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system.

Authors:  E I Ginns; P V Choudary; B M Martin; S Winfield; B Stubblefield; J Mayor; D Merkle-Lehman; G J Murray; L A Bowers; J A Barranger
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

4.  Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients.

Authors:  E H Kolodny; M D Ullman; H J Mankin; S S Raghavan; J Topol; J L Sullivan
Journal:  Prog Clin Biol Res       Date:  1982

5.  Evolution of the hemoglobin S and C genes in world populations.

Authors:  Y W Kan; A M Dozy
Journal:  Science       Date:  1980-07-18       Impact factor: 47.728

6.  Cross-reacting material in Gaucher disease fibroblasts.

Authors:  E Beutler; W Kuhl; J Sorge
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

  6 in total
  16 in total

1.  Linkage of the PvuII polymorphism with the common Jewish mutation for Gaucher disease.

Authors:  A Zimran; T Gelbart; E Beutler
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

2.  Molecular analysis of Japanese Gaucher disease.

Authors:  T Ohashi; Y Eto
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 3.  Gene transfer into the nervous system.

Authors:  X O Breakefield; A I Geller
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

4.  Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

Authors:  S Tsuji; B M Martin; J A Barranger; B K Stubblefield; M E LaMarca; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  DNA markers in primate models of human disease.

Authors:  J E Hixson
Journal:  Genetica       Date:  1987-08-31       Impact factor: 1.082

6.  Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.

Authors:  J Sorge; C West; B Westwood; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Galactocerebrosidase activity in somatic cell hybrids derived from twitcher mouse/control human fibroblasts is associated with human chromosome 17.

Authors:  T A Lyerla; J T Konola; M C Skiba; S Raghavan
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

Review 8.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.

Authors:  A Zimran; J Sorge; E Gross; M Kubitz; C West; E Beutler
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

10.  Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer.

Authors:  J Sorge; W Kuhl; C West; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.